Molecular biology of glioma.

doi:10.1007/978-1-4614-3146-6_1

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Molecular biology of glioma.

Advances in experimental medicine and biology - 1 Jan 2012

Marumoto Tomotoshi, Saya Hideyuki

Abstract excerpt

Glioblastoma (GBM) is the most aggressive form of glioma. Despite ceaseless efforts by researchers and physicians to find new therapeutic strategies, there have been no significant advances in the treatment of GBMs for several decades and most patients with GBM die within one and half years of diagnosis. Undoubtedly, one reason for this is the insufficient understanding of the initiation and progression of GBMs...

Topics

Brain Neoplasms
Epigenesis, Genetic
Gene Expression Regulation, Neoplastic
Glioblastoma
Glioma
Humans
MicroRNAs
Models, Genetic
Molecular Biology
Mutation

Source

Open in PubMed

Identifiers

PMID: 22639155
DOI: 10.1007/978-1-4614-3146-6_1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics